Group
immunotherapy NOS
The data below refer to patients treated with immunotherapy NOS as the sole drug class,
excluding any concurrent use of drugs from other groups.
Combination therapy data are available in the section below.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.
Mifamurtide
No data
Nogapendekin alfa inbakicept
No data
Peginterferon Alfa-2b
No data
Sipuleucel-T
No data
Talimogene Laherparepvec
No data